Please login to the form below

Not currently logged in
Email:
Password:

drug-device combinations

This page shows the latest drug-device combinations news and features for those working in and with pharma, biotech and healthcare.

Mitsubishi buys Israel's NeuroDerm for $1.1bn

Mitsubishi buys Israel's NeuroDerm for $1.1bn

The deal will see it focus on a series of drug-device combinations for Parkinson’s disease, headed by phase III candidate ND0612. ... The $39-per-share deal will see NeuroDerm merged with Mitsubishi's Israeli unit to become a wholly-owned subsidiary

Latest news

  • Medtronic and Samsung partner on diabetes device Medtronic and Samsung partner on diabetes device

    In addition to this, Sanofi also worked with Medtronic to develop drug device combinations for patients with type 2 diabetes. .

  • Sanofi and Medtronic to develop drug-device combos in diabetes Sanofi and Medtronic to develop drug-device combos in diabetes

    Sanofi has entered a partnership with US-based medical device firm Medtronic to develop drug-device combinations for people with type 2 diabetes.

  • Drug-device convergence Drug-device convergence

    Drug-device combinations have been around for more than 50 years, with transdermal patches delivering drugs, stents coated with anticoagulants, inhaled medicines and drugs bundled alongside diagnostics all coming under the ... All told, the global market

  • MHRA launches virtual 'innovation office' MHRA launches virtual 'innovation office'

    The UK regulator wants to help firms working on things like novel drug-device combinations or nanomedicines to navigate its regulatory processes through early dialogue. ... Areas of technology that are a current focus for the regulator include novel

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Spectrum Regulatory Solutions

    We serve the following industry segments: pharmaceutical, biologics, medical devices, drug device combinations, nutraceuticals, functional foods and veterinary.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

InSite Events™ National Pharma Meeting: A Customer Story
How our client leveraged Impetus Digital’s white-glove service, 360° coverage and care, and award-winning InSite Events™ platform to successfully transfer their annual national meeting online....
Fear or encouragement, which is best to drive behaviour change?
The communications industry depends on fear of the perceived loss of something, in order to create the hope found in a product benefit. But, if if left too long unchecked,...
The unheard, unseen, and uncorrected effects of COVID-19
The disproportionate effects of the pandemic have been highlighted amongst ethnic minorities, so is it likely that ethnic minorities will be more worried about participating? And could this exacerbate inequalities...

Infographics